Vireo Health Announces Filing of Form S-8 with the SEC

Vireo Health International Inc., (“Vireo” or the “Company”) (CNSX: VREO, OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, today announced the filing of a registration statement on Form S-8 with the United States Securities and Exchange Commission (“SEC”).

The Form S-8 registers previously issued securities under the Company’s equity incentive plans with the SEC, as well as shares which may be issued under similar plans in the future with the approval of the Company’s Board of Directors. These securities were previously only registered in Canada.

“After becoming a full SEC reporting company earlier this year, today’s filing represents another administrative step in our planned transition to listing on a U.S. exchange sometime in the future,” said Chief Executive Officer, Dr. Kyle Kingsley, M.D. “We plan to maintain our public listing in Canada, but we expect to continue experiencing significant increases in demand for our shares in the United States and we believe it’s critical that all shares be registered with the SEC as soon as practicably possible.”

Support us by becoming a Patreon supporter! Become a Patron!

Leave a Reply

Your email address will not be published. Required fields are marked *